Skip to main content
TipRanks
Go Ultimate75% OFF

Loblaw Companies (LBLCF) AI Stock Analysis

108 Followers
LBLCF

Loblaw Companies

(Other OTC:LBLCF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Steady growth and resilient marginsConsistent revenue growth combined with stable gross margins indicates a resilient core retail model. Modestly improving operating and net margins suggest Loblaw is converting scale, mix, and operating execution into stronger earnings power despite grocery retail’s structurally thin profitability.
Negative Factors
Meaningful financial leverageAlthough leverage improved in the latest period, debt remains significant relative to equity for a defensive retailer. This can reduce financial flexibility, increase sensitivity to interest and consumer pressures, and constrain the funds available for growth investments or shareholder returns during weaker conditions.

Loblaw Companies (LBLCF) vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%LBLCF+13.09%SPY+14.28%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$55.97B
Dividend Yield
0.88%
Average Volume (3M)
193.08K
Price to Earnings (P/E)
28.9
Beta (1Y)
-0.17
Revenue Growth
4.57%
EPS Growth
17.66%
Country
US
Employees
220,000
Sector
Consumer Defensive
Sector Strength
62
Industry
Grocery Stores

Loblaw Companies Business Overview & Revenue Model

Company Description

Loblaw Companies Limited is a prominent Canadian enterprise primarily focused on food and pharmacy, delivering a wide array of products and services across the nation. Its diverse business interests encompass grocery, pharmacy, health and beauty, app...

Loblaw Companies Earnings Call Summary

Earnings Call Date:Jul 30, 2026(Q2-2026)|% Change Since:3.58%|Next Earnings Date:Nov 19, 2026
Earnings Call SentimentPositive

The call emphasized broad operational strength: solid revenue and adjusted EPS growth, improving adjusted EBITDA, robust pharmacy momentum, strong e-commerce expansion, successful store openings (including an exceptionally strong T&T California debut), and a strengthened capital-return program. Management also highlighted positive early signs from GLP-1 generics as a potential gross margin tailwind. Near-term negatives were acknowledged but appear manageable: ramp costs for new distribution capacity and stores, some category/timing headwinds (Easter shift, tobacco/liquor, tariff timing), a one-month reporting timing impact from the PC Financial sale, and external risks like fuel-price volatility. Overall, the positives and strategic tailwinds substantially outweigh the manageable short-term headwinds.

Positive Updates

Top-line growth and strong profitability
Total revenue (including PC Financial) of $15.0B, up 4.1% year-over-year. Total company adjusted EBITDA increased 5.1% to $1.9B with adjusted EBITDA margin improving ~10 basis points. Adjusted diluted net earnings per common share rose 11.9% to $0.66 (GAAP diluted EPS $0.64, up 8.5%).

Negative Updates

Consumer remains value-focused, trade-down pressure
Customers continue to seek value, promotions and trade down to discount banners; management notes increased private label uptake and changes in shopping patterns, which underline ongoing pricing pressure and the need for promotional investment.

Company Guidance

Loblaw reiterated that it expects Retail earnings to grow faster than sales and guided to adjusted net earnings per common share growth in the high single digits for the year despite a Q3 timing headwind (only one month of EQB earnings will be recognized in Q3); management expects continued consistent top‑line sales growth in Q3, ~75 store openings this year, ongoing consistent free cash‑flow growth and a larger NCIB (now targeting $2.1 billion of share repurchases for the year, up $200 million; $552 million repurchased in Q2 and $1.2 billion year‑to‑date), and plans to increase its EQB stake from ~19.9% toward ~25%; they also expect GLP‑1s going generic to drive double‑digit revenue growth in 2027 with gross profit dollars and margin rising by more than top‑line growth, and noted strong returns (ROE 27.2%, ROC 12.5%) alongside confidence in gross margin outlook.

Loblaw Companies Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

LBLCF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:SAPTSE:SAP72OutperformCAD 17.42B30.718.44%1.82%-7.13%―
TSE:DOLTSE:DOL63NeutralCAD 58.01B43.6197.52%0.21%17.86%10.53%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
TSE:MRUTSE:MRU62NeutralCAD 20.47B23.3912.87%1.65%2.94%-8.82%
TSE:WNTSE:WN60NeutralCAD 40.93B42.3920.42%1.12%3.74%-0.07%
TSE:EMP.ATSE:EMP.A57NeutralCAD 11.20B51.494.27%1.83%2.45%-67.24%

* Consumer Defensive Sector Average

Performance Comparison

-10%0%10%20%LBLCFTSE:DOLTSE:EMP.ATSE:MRUTSE:SAPTSE:WNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
LBLCF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
LBLCFLoblaw Companies48.436.5415.60%
TSE:DOLDollarama218.4724.8912.86%
TSE:EMP.AEmpire Co Cl A Nv50.460.080.16%
TSE:MRUMetro Inc.98.493.123.27%
TSE:SAPSaputo Inc.44.468.0922.23%
TSE:WNGeorge Weston Limited110.6421.6324.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.